Data / Form D filings / Starr Life Sciences Corp.
Starr Life Sciences Corp.: Form D filings
Starr Life Sciences Corp., a health care company in Oakmont, PA, filed 4 Form D notices with the SEC between 2009 and 2011. The latest, on July 1, 2011, reports $519,862 sold of a $700,000 offering to 18 investors.
Find out what Starr Life Sciences Corp. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 333 ALLEGHENY AVENUE, SUITE 300, Oakmont, PA, 15139
- Phone
- (866) 978-2779
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Pennsylvania
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1365950
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 1, 2011 | Amendment | $700,000 | $519,862 | $180,138 | 18 | Oct 12, 2010 | sec.gov |
| Oct 25, 2010 | New notice | $500,000 | $382,160 | $117,840 | 18 | Oct 12, 2010 | sec.gov |
| Oct 25, 2010 | New notice | $3,702,500 | $3,702,500 | $0 | 20 | Oct 12, 2010 | sec.gov |
| Jun 23, 2009 | Amendment | $2,150,000 | $1,787,000 | $363,000 | 14 | Jan 30, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Steven D. Fulton | Executive Officer | |
| Christopher A. Brodman | Director | |
| Robert D. Crouch | Director | |
| Michael D. Lang | Executive Officer, Director | |
| Daniel Bevevino | Executive Officer | |
| Patrick B. Stewart | Director | |
| Thomas B. Feroah | Director | |
| Donald B. Wagner | Director | |
| Eric W. Starr | Director, Promoter |
Other health care companies in Pennsylvania that filed recently
- Septal Solutions, Inc. $7.3 million · Oct 27, 2026
- Lungpacer Medical, Inc. $7.8 million · Oct 14, 2026
- Plowshare Holdings LLC $7.8 million · Oct 14, 2026
- Peca Labs, Inc. $12.8 million · Oct 9, 2026
- McAllen Digestive Surgery Center, LLC offering · Sep 30, 2026
- Toetal Solutions, Inc. $50,000 · Sep 24, 2026
Every Form D from the week of Jun 27, 2011 · All recent filings in Pennsylvania · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Starr Life Sciences Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.